Article

Bromhexine, for Post Exposure COVID-19 Prophylaxis: A Randomized, Double-Blind, Placebo Control Trial

2021-12-20

Abstract excerpt

Background: Limited number of medications are available for the post-exposure prophylaxis of COVID-19 infection. Whether bromhexine can prevent or mitigate symptomatic infection after virus exposure is undetermined.<br><br>Methods: A multi-center randomized; double-blind, placebo-controlled clinical trial was conducted. The 372 adults (≥18 years) who had close contact within 4 days with a household member with con...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 741de92f-feba-5fdf-9d16-cae411e837ef
DOI: 10.2139/ssrn.3989849

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Bromhexine, for Post Exposure COVID-19 Prophylaxis: A Randomized, Double-Blind, Placebo Control TrialDOI 10.2139/ssrn.3989849Read

Bromhexine, for post exposure COVID-19 prophylaxis: A Randomized, Double-Blind, Placebo Control TrialSemantic proximity Read

A Proposed Randomized, Double Blind, Placebo Controlled Study Evaluating Doxycycline for the Prevention of COVID-19 Infection and Disease In Healthcare Workers with Ongoing High Risk Exposure to COVID-19Semantic proximity Read

Comparative efficacy and safety of current drugs against COVID-19: A systematic review and network meta-analysisSemantic proximity Read

Pilot Survey Among Patients Taking Bromhexine Prophylactically Against InfluenzaSemantic proximity Read

Efficacy and Safety Evaluation of Arbidol in Patients with COVID-19Semantic proximity Read

Bromhexine Prophylaxis and Pharmacologically Attenuated Natural Immunization: A New Paradigm of Host-Directed Modulation of SARS-CoV-2 and Influenza Virus InfectionsSemantic proximity Read

Favipiravir and/or Nitazoxanide: a randomized, double-blind, 2x2 design, placebo-controlled trial of early therapy in COVID-19 (FANTAZE).Semantic proximity Read

Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trialSemantic proximity Read

A 6-week time period may not be sufficient to identify potential adverse events following COVID-19 vaccinationSemantic proximity Read

A randomized, placebo-controlled trial of a nasal spray solution containing broadly potent neutralizing antibodies against SARS-CoV-2 variants in healthy volunteersSemantic proximity Read

A phase 3, randomised, double-blind, placebo-controlled clinical trial for adult evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine (ABDALA-3 Study)Semantic proximity Read

Impact of non-pharmaceutical interventions against COVID-19 in Europe: A quasi-experimental studySemantic proximity Read